Toxicological assays in the evaluation of safety assessment of fibrinolytic enzymes-Reference-Cited by-同舟云学术

Toxicological assays in the evaluation of safety assessment of fibrinolytic enzymes

Published:2024-08-19 Issue: Volume: Page:1-11
ISSN:0148-0545
Container-title:Drug and Chemical Toxicology
language:en
Short-container-title:Drug and Chemical Toxicology

Author:

Marques da Silva Marllyn¹,Santana Moura Yanara Alessandra¹,Leite Arthur Hipólito Pereira²,Souza Kerolayne Lira Da Silva³,Brandão Costa Romero Marcos Pedrosa³,Nascimento Thiago Pajeú⁴,Porto Ana Lúcia Figueiredo¹,Bezerra Raquel Pedrosa¹

Affiliation:

1. Laboratório de Avanços em Biotecnologia de Proteínas e Tecnologia de Bioativos, Departamento de Morfologia e Fisiologia Animal, Universidade Federal Rural de Pernambuco, Recife, Pernambuco, Brasil

2. Departamento de Bioquímica, Centro Universitário de Patos – UNIFIP, Patos, Paraíba, Brasil

3. Instituto Ciências Biológicas, Universidade de Pernambuco, Recife, Pernambuco, Brasil

4. Campus Professora Cinobelina Elvas, Universidade Federal do Piauí, Bom Jesus, Piauí, Brasil

Funder

Foundation for Science and Technology of the State of Pernambuco

National Council for Scientific and Technological Development

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/01480545.2024.2367561

Reference82 articles.

1. Thrombolytic and anticoagulant efficiencies of purified fibrinolytic enzyme produced from Cochliobolus hawaiiensis under solid‐state fermentation

2. Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation

3. Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010

4. Biocompatibility

5. Evaluation of the Bleeding Intensity of Patients Anticoagulated with Warfarin or Dabigatran Undergoing Dental Procedures